Children's Ibuprofen Oral Suspension USP — Class II drug recall D-0300-2020
Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2019-11-06, distributed nationwide. Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic mate
| Recall number | D-0300-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States |
| Recall initiated | 2019-09-27 |
| Classified | 2019-11-05 |
| Reported by FDA | 2019-11-06 |
| Terminated | 2023-08-31 |
| Distributed | Nationwide (US) |
| Quantity | 182,986 bottles |
| NDC | 51672-2130, 51672-2130-01, 51672-2130-08 |
| Lot numbers | 12/20, 4/20, 9/20, A972934375, A973034375, E875131667, E875231667, J871033189, J871133189 |
Product
Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free, 4 fl. oz. (120 mL), Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-2130-8
Reason for recall
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0300-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.